Kettil Cedercreutz
@kettilc
CEO, Temprian Therapeutics, developing solutions for the treatment of vitiligo.
ID: 63620601
http://www.tempriantherapeutics.com 07-08-2009 02:53:56
35 Tweet
42 Followers
68 Following
The Strategic Management Journal's 2017 impact factor is 5.482 (over 30k citations in total) making it one of the leading journals in management & business. Thanks to all the editors, reviewers, authors, Strategic Management Society and Michael Wiley for making this possible